Αποτελέσματα Αναζήτησης
1 Οκτ 2019 · Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
- Table 2
Accepted as introduced in the 2005 ATS/IDSA...
- rccm.201908-1581ST
We would like to show you a description here but the site...
- Cethromycin Versus Clarithromycin for Community-Acquired Pneumonia
INTRODUCTION. Community-acquired pneumonia (CAP) is the 8th...
- Cem-101
MATERIALS AND METHODS. This randomized, double-blind study...
- Table 2
26 Ιουν 2018 · The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea.
14 Αυγ 2018 · A 2015 prospective, multi-center study by the Centers for Disease Control and Prevention identified a responsible pathogen in only 38% of cases of community-acquired pneumonia (CAP) in adults requiring hospitalization. 4 CAP is an infection of the lung parenchyma that is acquired outside of hospitals or extended-care facilities. 5 Viral pathogen...
15 Ιουλ 2020 · The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) recently updated their recommendations on the diagnosis and treatment of community-acquired...
6 Δεκ 2021 · Severe pneumonia is associated with high mortality (short and long term), as well as pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of adequate antimicrobial treatment for severe pneumonia are crucial in improving survival among critically ill patients.
2 Απρ 2015 · The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non–intensive care unit (ICU) hospital wards is ...
Outpatient treatment is recommended in patients with Pneumonia Severity Index (PSI) risk class I or II with a PSI score ≤70 (low risk), or a CURB-65 score of 0-1 (low severity). Empiric oral antibiotics are recommended: amoxicillin, doxycycline, or a macrolide (e.g., azithromycin or clarithromycin). Only use a macrolide in areas with ...
